Chief Program Officer
Laura is a geneticist specialised in advanced therapies and regulatory affairs with a special interest in paediatric medicines and rare disorders.
She worked for many years in Drug Discovery coordinating early phase R&D projects. More recently she moved into clinical development coordinating large multinational paediatric projects.
Laura is Chief Program Officer at Penta and provides scientific coordination and regulatory support for several projects and applications in Penta’s portfolio.